Post by
tamaracktop on Sep 08, 2024 8:30am
No analysts, no underwriters.
The last two financings have been non-brokered private placements.
The last financing that was underwriter was the convertible debentures announced in June 2023.
It was done by Research Capital on a "best efforts" basis.
The company had hoped to raise $5 million.
They raised $3,030,000.
Pascali bought $2 million of that.
This company will never find an underwriter again.
They seem very reluctant to file a prospectus.
No analyst coverage, and no underwriter.
That's just plain grim.
Comment by
tamaracktop on Sep 08, 2024 6:51pm
"The last financing that was underwriter was the convertible debentures announced in June 2023. It was done by Research Capital on a "best efforts" basis." It took RC one month to close that deal. It took them a month to sell $1,030,000 units at a buck.
Comment by
tamaracktop on Sep 08, 2024 6:54pm
If that was a good offering, any half decent individual broker could have sold the whole deal in one day. An entire firm couldn't do it in a month.
Comment by
nedstar71 on Sep 08, 2024 7:24pm
Why have you not commented on the latest financing attempt by Exro? Seems weird after pumping that stock for years you only crawl out from under your rock when it dead cat bounces a few pennies. Also, why have the only stocks you've ever posted positively about on stockhouse in the last 17 years ALL crashed and burned? Seems implausible.
Comment by
tamaracktop on Sep 09, 2024 11:56am
"The lot should reach out to Peters new bride,cause in real life she didn't marry Peter for another 25 years of R&D ( research and destruction to quote Peter)" The fact that this inane statement and everything that came with it received 10 likes speaks volumes about this board. It goes a long way to explaining how anyone could possibly still be long this stock.